€
45.20
Jan 16
Business Description
Dechra Pharmaceuticals PLC
ISIN : GB0009633180
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.15 | |||||
Equity-to-Asset | 0.48 | |||||
Debt-to-Equity | 0.67 | |||||
Debt-to-EBITDA | 5.17 | |||||
Interest Coverage | 0.14 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 4.05 | |||||
Beneish M-Score | -2.63 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 10.3 | |||||
3-Year EBITDA Growth Rate | -10.2 | |||||
3-Year EPS without NRI Growth Rate | 0.9 | |||||
3-Year FCF Growth Rate | -19.2 | |||||
3-Year Book Growth Rate | 4 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 11.91 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 82.51 | |||||
9-Day RSI | 71.63 | |||||
14-Day RSI | 65.09 | |||||
6-1 Month Momentum % | 3.76 | |||||
12-1 Month Momentum % | 34.76 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.85 | |||||
Quick Ratio | 1.53 | |||||
Cash Ratio | 0.45 | |||||
Days Inventory | 223.88 | |||||
Days Sales Outstanding | 62.66 | |||||
Days Payable | 83.01 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.31 | |||||
Dividend Payout Ratio | 0.48 | |||||
3-Year Dividend Growth Rate | 11.9 | |||||
5-Year Yield-on-Cost % | 0.61 | |||||
3-Year Average Share Buyback Ratio | -1.8 | |||||
Shareholder Yield % | -8.01 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 55.98 | |||||
Operating Margin % | 0.83 | |||||
Net Margin % | -3.66 | |||||
FCF Margin % | 4.34 | |||||
ROE % | -3.7 | |||||
ROA % | -1.82 | |||||
ROIC % | 0.36 | |||||
3-Year ROIIC % | -8.97 | |||||
ROC (Joel Greenblatt) % | 2.36 | |||||
ROCE % | 0.57 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio without NRI | 40.91 | |||||
Shiller PE Ratio | 101.55 | |||||
PEG Ratio | 13.2 | |||||
PS Ratio | 5.79 | |||||
PB Ratio | 5.83 | |||||
Price-to-Free-Cash-Flow | 131.95 | |||||
Price-to-Operating-Cash-Flow | 69.28 | |||||
EV-to-EBIT | 619.41 | |||||
EV-to-Forward-EBIT | 49.47 | |||||
EV-to-EBITDA | 49.55 | |||||
EV-to-Revenue | 6.34 | |||||
EV-to-Forward-Revenue | 5.32 | |||||
EV-to-FCF | 145.09 | |||||
Price-to-Projected-FCF | 4.07 | |||||
Price-to-DCF (Earnings Based) | 1.83 | |||||
Price-to-DCF (FCF Based) | 11.65 | |||||
Price-to-Median-PS-Value | 1.03 | |||||
Earnings Yield (Greenblatt) % | 0.16 | |||||
FCF Yield % | 0.76 | |||||
Forward Rate of Return (Yacktman) % | 3.95 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Dechra Pharmaceuticals PLC Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 881.573 | ||
EPS (TTM) (€) | -0.291 | ||
Beta | 0 | ||
Volatility % | 46.8 | ||
14-Day RSI | 65.09 | ||
14-Day ATR (€) | 0.400677 | ||
20-Day SMA (€) | 44.39 | ||
12-1 Month Momentum % | 34.76 | ||
52-Week Range (€) | 28 - 45.2 | ||
Shares Outstanding (Mil) | 113.91 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Dechra Pharmaceuticals PLC Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Dechra Pharmaceuticals PLC Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Dechra Pharmaceuticals PLC Frequently Asked Questions
What is Dechra Pharmaceuticals PLC(FRA:1PK)'s stock price today?
When is next earnings date of Dechra Pharmaceuticals PLC(FRA:1PK)?
Does Dechra Pharmaceuticals PLC(FRA:1PK) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |